Harpoon Therapeutics Presents Data for New ProTriTAC™
Results support further investigation of two new ProTriTAC™ protease-activated T cell engager development candidates, with demonstrated therapeutic...
Stay updated with breaking news from Preclinical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results support further investigation of two new ProTriTAC™ protease-activated T cell engager development candidates, with demonstrated therapeutic...
ALBANY, N.Y., April 13, 2023 /PRNewswire/ -- YDS Pharmatech, a computational drug discovery company specializing in induced proximity, today annou...
Dublin, April 07, 2023 (GLOBE NEWSWIRE) -- The "Global Preclinical Brain Imaging Market, By Imaging Type, By End User, Estimation & Forecast,...
/PRNewswire/ -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing neurodegenerative diseases, has...
Operator: Good afternoon and welcome to the PepGen Conference Call to discuss PepGen's Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Developments.